DNA/RNA

Description
The gene encompasses 108081 bp of DNA with 19 exons.
Transcription
ABCB5 encodes a 2784 bp mRNA. The coding region consists of exon 4-19, while exon 1-3 and 3' part of exon 19 are non-coding.
Protein
Description
Only 2 isoforms, ABCB5alpha and ABCB5beta have been studied so far. ABCB5 P-gp (isoform 1, also known as ABCB5beta) contains 812 amino acids (P-gp is short for "permeability glycoprotein"). ABCB5alpha contains only 131 amino acids.
Expression
ABCB5 is reported to be expressed in many different tissues, including brain, intestine, kidney, mammary gland, testis and skin. Besides, ABCB5 has a significantly higher expression level in malignant melanomas than in benign melanocytes.
Localisation
ABCB5 P-gp is located in the plasma membrane, with 5 transmembrane helices flanked by both extracellular and intracellular ATP-binding domains.
Function
ABCB5 belongs to the ATP-binding cassette (ABC) transporter superfamily of integral membrane proteins. These proteins participate in ATP-dependent transmembrane transport of structurally diverse molecules. ABCB5 mediates melanoma doxorubicin resistance via its function as a doxorubicin efflux transporter. In addition, ABCB5 P-gp can regulate progenitor cell fusion. However, ABCB5alpha alone may be non-functional.
Homology
ABCB5 shares 54% and 56% amino acid identity with ABCB1 and ABCB4, respectively.
ABCB5 gene on chromosome 7p.
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Implicated in
Malignant melanoma
Note Tissue microarray showed that primary and metastatic malignant melanomas expressed significantly more ABCB5 protein than benign melanocytic nevi, thick primary melanomas more than thin primary melanomas, and melanomas metastatic to lymph nodes more than primary lesions. Melanoma cell subpopulations identified by expression of ABCB5 were enriched for human malignant-melanomainitiating cells (MMIC). Besides, ABCB5 also mediates chemoresistance in human malignant melanoma.
Chemoresistance in human malignant melanoma
Oncogenesis ABCB5 P-gp mediates melanoma doxorubicin resistance via its function as a doxorubicin efflux transporter.
